Purpose Golden retriever muscular dystrophy (GRMD) is a widely used canine model of Duchenne muscular dystrophy (DMD). Recent studies have shown that magnetic resonance imaging (MRI) can be used to non-invasively detect consistent changes in both DMD and GRMD. In this paper, we propose a semiautomated system to quantify MRI biomarkers of GRMD. 
Introduction
Duchenne muscular dystrophy (DMD) is a fatal, X-linked, muscle disorder characterized by progressive degeneration of skeletal and cardiac muscle [1] . It is the most common form of muscular dystrophy, affecting approximately 1 in 3,500 live born males [2, 3] . DMD is caused by mutations in the DMD gene, which encodes the cytoskeletal protein dystrophin. Proximal leg muscle weakness is generally the first observed clinical manifestation of DMD. The ensuing progressive muscle weakness usually leaves affected boys severely disabled by their early teenage years and results in death due to respiratory and cardiac failure [2] . Currently, no therapy halts or reverses progression of DMD. Although cellular and gene therapies are promising, key questions must first be addressed in relevant animal models. Spontaneous forms of X-linked muscular dystrophy due to dystrophin deficiency have been characterized in mice, [4] cats, [5] , and dogs [6, 7] . Because golden retriever muscular dystrophy (GRMD) dogs develop progressive and fatal disease strikingly similar to the human condition, this model has increasingly been used in preclinical trials [8] .
Although muscle biopsy has been widely used in the diagnosis of muscle diseases including DMD, the invasiveness limits its use and now most patients are diagnosed using molecular methods. As a result, non-invasive outcome measures, especially quantitative methods, are needed for studies in animal models and in DMD patients. Magnetic resonance imaging (MRI) has been used as to provide data on disease progression in both natural history and treatment trials for GRMD [9] [10] [11] and DMD [12] [13] [14] . Observed MRI changes in DMD include an increase in T2 and decrease in T1 relaxation times due to accumulation of fat in affected muscles. There is an associated increase in whole body fat and decrease in muscle mass [12, 15] . These MRI imaging features have been successfully correlated with functional measurements [16, 17] . In fact, one study suggested that MRI is more sensitive than functional tests in predicting disease progression [15] . The potential role of MRI as a biomarker in the GRMD model has also been reported [9] [10] [11] . In the Thibaud et al. study [10] , two-month-old GRMD and carrier dogs were assessed. GRMD dogs had an abnormally high T2-/T1-weighted signal ratio, greater T2-weighted image heterogeneity, and more enhanced muscle signal on T1-weighted images after Gd-DTPA injection compared to heath controls. A subsequent study of 3-month-old to 7-year-old muscular dystrophy dogs by Kobayashi et al. [9] demonstrated increased T2 values and fat-suppressed T2-weighted intensity, as well as greater enhancement with gadolinium, consistent with inflammation and necrosis. Yokota et al.'s study [11] contrasted muscular dystrophic dogs treated with a morpholino cocktail with both untreated muscular dystrophic dogs and wild-type littermates from 2 months to 5 years of age. Treated muscular dystrophic dogs had consistently decreased T2 values compared to those that were untreated.
In existing DMD and GRMD studies, muscle segmentation and MRI-based biomarker quantification are manually driven [9, 10, 18] . Because full manual assessment is cumbersome, time consuming, and subject to rater errors, computerized quantification methods are needed for advancing MRI biomarkers as objective surrogate outcome measures for preclinical and clinical trials. In this paper, we present a novel semiautomated MRI quantification tool that provides potential imaging biomarkers for monitoring disease progression in preclinical and clinical trials of GRMD and DMD. In addition, we propose new run-length matrix-based MRI statistical texture analysis technique to create statistical texture biomarkers, which discriminates between normal and GRMD dogs.
Method

Study subjects
The Institutional Animal Care and Use Committee (IACUC) approval was obtained for this study [IACUC Protocol 09-011.0, Natural History and Immunological Parameters in the German Shorthaired Pointer Muscular Dystrophy (GSHPMD) Dog, PI Joe Kornegay, DVM, PhD] at the University of North Carolina at Chapel Hill (UNC-CH). This study was supported by the Muscular Dystrophy Association and compared phenotypic features in GRMD, GSHPMD, and normal dogs. The database included 10 GRMD and 8 normal dogs on which MRI data are reported here. All the dogs were produced through a canine x-linked muscular dystrophy colony maintained at UNC-CH. Dogs were used and cared for according to principles outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Data from MRI were included in a range of phenotypic tests performed over their first year of life. The proximal pelvic limbs of all dogs were scanned at approximately 3 and 6 months of age. Additional studies were completed at 9 months in five GRMD and four normal dogs. Totally, 45 MRI scans were acquired.
Dogs were scanned on a Siemens 3T Allegra Head-Only MRI scanner with a circular polarization (CP) head coil or Siemens 3T Tim Trio Whole-Body MRI scanner with a 32-channel body coil at the UNC Biomedical Research Imaging Center (BRIC). Dogs were anesthetized, placed on an MRI gantry in the sternal (prone) position with the pelvic limbs extended and positioned in the coil centered at the midpoint of the femur.
The image protocol of the MRI scans is listed in Table 1 . T2-weighted (T 2 w) image sequence Fig. 1a was acquired using a variable-flip-angle turbo spin echo (TSE) sequence. No fat saturation magnetization preparation was applied. T2-weighted fat-suppressed (T 2 fs) images sequence was then acquired using the same variable-flip-angle TSE sequence Fig. 1b with the same scanning parameters except that a fat saturation preparation was applied. During the fat saturation procedure, a frequency-selection pulse was applied to excite the fat; dephasing gradient pulses were applied immediately after the frequency-selection pulse to spoil the fat signal. Thus, the remaining signal contained close to zero contribution from fat. To obtain T2 value maps, a multi-slice, ten-echo CarrPurcell-Meiboom-Gill (CPMG) sequence (T 2 FIT) was applied with the parameters listed in Table 1 . To make the acquisition time manageable, the T 2 FIT only covered the mid-femur section of the proximal pelvic limbs. The computation of T2 value maps is described in detail in Section "Calculation of T2 value maps".
Image analysis method
Our biomarker quantification scheme is composed of three modules: muscle segmentation, preprocessing, and biomarker analysis. As a prerequisite, we first segmented six major proximal pelvic limb muscles of dogs in the MRI images. Then, the process continued with several preprocessing steps and the calculation of the MRI biomarker including texture-based biomarkers. Finally, regional statistics of the MRI biomarkers were calculated for each segmented muscle, and these biomarkers were assessed in the context of GRMD disease progression.
Muscle segmentation
In this study, we quantified MRI-based biomarkers of GRMD dogs and normal littermates in six proximal pelvic limb muscles: cranial sartorius (CS), rectus femoris (RF), semitendinosus (ST), biceps femoris (BF), gracilis (GR), and adductor magnus (AD). These muscles were selected to have a balanced representation of flexors and extensors, variable sizes and variable histopathological progression, based on our prior pathologic studies [6, 19] . For instance, histopathologic changes in the CS occur earlier than those in the vastus lateralis [20] . For the purpose of tool development and feasibility/validation analysis in this study, we focused on the left limbs of GRMD and normal dogs. As the anatomical structures of the left and right limbs have a relatively high degree of bilateral symmetry, that is, differences between the left and a mirrored right limbs of the same subject are expected to be small when compared to inter-subject differences. We expect that muscle segmentation of the right limb and the subsequent biomarker quantification can be obtained by mirroring the MR images and by applying the segmentation and processing framework to this mirrored right limb. This processing will need to be tested in our future work.
In existing DMD and GRMD MRI studies, muscles were usually segmented manually. To reduce the workload of muscle segmentation, the muscles are generally segmented in a limited range, typically mid-section in the transverse view. For instance, in our previous work [21] , we manually segmented the muscles in five slices close to the femoral midpoint. The midpoint of the femur was determined by first identifying the femoral head and condyle as the proximal and distal anatomical limits, respectively, and then dividing the distance between these landmarks in half. As the large majority of a muscle is excluded using such a limited segmentation approach, measurements of muscle volume as well as other biomarkers are quite likely inaccurate (see section "Results" for our evaluation on this topic). To address this issue, we performed an interpolation-based semiautomated whole muscle segmentation. First, prior to the segmentation, the MRI data were rigidly realigned to a standardized coordinate space, where transverse slices were perpendicular to the femur axis and the sagittal and dorsal slices were parallel to the lateral and cranial axes, respectively. An initial segmentation was then performed by three of the authors (ZF, YS, and JW), each manually delineating the outline of every muscle in every fifth slice only (per muscle, an average of 24 manually segmented slices) using the ITK-SNAP software (www.itksnap.org) [22] . The manual segmentation was performed in unbiased fashion, that is, the raters were blinded to the diagnostic information of the dogs and blinded to segmentations from other raters. Thus, the manual segmentation of the muscles was unbiased. Figure 2a shows the manual segmentation of the six muscles of a normal dog in a transverse slice. The segmentations of the remaining slices (4 slices between each 2 manually segmented slices) were then interpolated via a straightforward linear interpolation scheme from the neighboring manually segmented slices. Figure 2b shows the interpolated muscle volumes in threedimensional (3D) views. Given the non-folded appearance of proximal pelvic limb muscles, we did not expect a large error for such an interpolated segmentation approach.
Unlike the limited mid-femur range segmentations, this straightforward interpolation scheme allowed us to compute a set of MRI biomarkers, incorporating intensity information across most of the entire muscle's length. We created a reference data set to assess the semiautomated segmentation method. ZF manually delineated the full muscles of CS, RF, and ST in the MRI scans of two normal dogs and two GRMD dogs. We used the biomarkers (Section "Biomarker analysis") calculated in the manually segmented muscles as the reference standard. We employed the percent error ratio D Eq. (1) of all biomarkers calculated in the evaluated muscle segmentation (Be) and reference muscle segmentation (Br, manual muscle segmentation) as the performance metric to measure agreement between our biomarker quantification tool and the reference standard.
Preprocessing
The preprocessing was divided into five steps: (i) intensity inhomogeneity correction, (ii) calculation of T2 value maps, (iii) registration of T 2 w, T 2 fs, and T2 value maps, (iv) intensity calibration of T 2 w and T 2 fs, and (v) calculation of MRI biomarker maps.
Intensity inhomogeneity correction Intensity inhomogeneity refers to the slow, non-anatomic intensity variations of the same tissue in a MRI image, typically caused by B1 inhomogeneity, receiver coil non-uniformity, or static field inhomogeneity [23] . We used the N4 algorithm [24, 25] to correct for such intensity inhomogeneities. N4 aims at correcting intensity inhomogeneity by seeking the multiplicative bias field that maximizes the high-frequency content in the intensity histogram.
Calculation of T2 value maps
We calculated T2 value maps on a voxel-by-voxel basis for the proximal pelvic limbs of dogs in the transverse plane of T 2 FIT by fitting an exponential decay curve to the signal intensity of the corresponding voxels using a linear-least-squares curve-fitting algorithm [26] . In T 2 FIT, the intensity of a voxel as a function of echo time is fit to a monoexponential function Eq. (2).
where i is an index corresponding to the ith TE of the T 2 FIT, and I i (x, y, z) is the image intensity for the voxel (x, y, z) in the ith TE of the T 2 FIT. The monomial coefficient from the linear-least-square curve fit was weighted inversely and assigned to each voxel of T2 value map as the final T2 value map value. The dynamic range of the T2 value map was 16 bits.
The central slice of a T2 value map obtained from the T 2 FIT is shown in Fig. 1c . T2 value maps are sensitive to signal from both water and fat tissue. Thus, T2 value maps capture changes in both fat and water content within muscles, such as those occurring due to disease progression. Furthermore, the T2 value maps are quantitative measurements (in ms) and not affected by the MR signal inhomogeneity. Thus, they can be directly employed for intra-and inter-subject comparisons.
Image registration Due to the possible presence of motion during the MRI acquisition, we co-registered the T 2 fs and T2 value maps to the T 2 w via standard rigid transformation using three translation parameters and three rotation parameters.
In the study presented in this paper, we used T 2 w as the fixed image as it provides better signal than the T 2 fs and higher resolution than the T2 value maps. We employed a mutual information metric [27] -based implementation available within the Insight Segmentation and Registration Toolkit (ITK, www.itk.org) to register T 2 fs and T2 value map to T 2 w for each MRI scan.
Intensity calibration In contrast to the T2 value maps, T 2 w and T 2 fs are not inherently calibrated. Thus, their intensity values cannot be directly compared across MRI scans from different subjects or even when acquired from the same subject at different times. To overcome this limitation, we calibrated the T 2 w and T 2 fs via an intensity-rescaling technique based on the mean intensity observed within subcutaneous fat regions. These fat regions were assumed to be composed of nearly pure fat in all dogs (independent of diagnosis). Because the fat signal is presaturated in T 2 fs, fat regions show very low intensity in T 2 fs but exhibit high intensity in T 2 w. For this calibration procedure, we first manually identified a subcutaneous fat region in three contiguous transverse slices at mid-thigh of the proximal pelvic limb in the registered T 2 w and T 2 fs. The mean intensity of the subcutaneous fat region in calibrated T 2 w was then (arbitrarily) set to 1000 and the one in calibrated T 2 fs was set to 100. Thus, the intensities I c of the calibrated T 2 w or T 2 fs were defined as:
where I (x, y, z) is the intensity at voxel (x, y, z) in the non-calibrated T 2 w or T 2 fs, and m 1 and m 2 are the mean intensities of the subcutaneous fat regions in non-calibrated T 2 w and T 2 fs, respectively.
Calculation of MRI biomarker maps
To evaluate the importance of the fat and water signals in the MRI images, we first quantified the loss in intensity between intensity calibrated T 2 w and T 2 fs to compute an estimate of the fat signal in each voxel and thus create a fat map (FM):
Because the fat signals were suppressed in the T 2 fs, the water signal in each voxel was simply estimated from the intensity of the voxel in the intensity calibrated T 2 fs image, allowing us to create a water map (WM) by
I T 2w (x, y, z) and I T 2 f s (x, y, z) are the intensities of voxel (x, y, z) in the denoised and registered T 2 w and T 2 fs. Denoising was established via standard anisotropic diffusion smoothing [28] . Anisotropic diffusion is a technique to reduce image noise without removing significant edges, lines, or other details that are important for the interpretation of the images. The performance of anisotropic diffusion smoothing is controlled by three parameters, the number of iterations, time step, and conductance, where the number of iterations and the time step are parameters used for controlling the smoothness of the image and conductance is used for controlling the edge contrast in the smoothed image. Without noise reduction, significant image noise may considerably impact the WM and FM map computation and could lead to incorrect water and fat signal-related biomarkers as the FM is calculated via direct differences on the T 2 w and the T 2 fs images. However, the smoothing process may have side effects, such as the fusion of fat and muscle signals at the boundary of the subcutaneous fat and muscle regions. This problem can be reduced by using a relatively high conductance to enhance the contrast of different tissues in the smoothed image. In this study, we empirically selected the parameters for anisotropic diffusion smoothing by visually observing the smoothing effect in a subset of MRI scans (3 normal and 3 GRMD scans). The number of iterations was set to 5, time step was set to 0.625 s, and conductance was set to 1.
Statistical texture biomarker Statistical texture analysis has been widely used in medical imaging applications to characterize texture patterns within the image [29] [30] [31] [32] . In muscular dystrophy MRI studies, dystrophic muscles usually present a unique texture pattern [33] . Thus, the statistical texture analysis technique has great potential to discriminate normal from dystrophic muscle on MRI [33, 34] . In this study, we automatically generated contiguous quadrilateral volumes of interest (VOIs) with a fixed size empirically chosen at 31 × 31 × 31 mm, as we intent to use the VOIs with a size not too big or too small comparing to the size of the proximal limbs of the GRMD dogs. Furthermore, we intentionally chose an odd number so that we could unambiguously determine the center voxel of each VOI. The distance between adjacent VOIs is 50 % of the VOI size, resulting in 50 % overlap between adjacent VOIs. Areas of the VOI outside the segmented muscle were ignored when calculating texture features.
Histogram texture features We employed standard intensity histogram-based first-order texture features and run-length matrix-based high-order texture features to analyze the muscle MR images [35] . We calculated the histogram texture features on the (intensity calibrated) T 2 w image as it provides better signal than the T 2 fs and higher resolution than the T2 value maps. Given the expected difference in MR appearance, we calculated standard deviation (SD) of the T 2 w intensities Eq. (3) for each muscle in each VOI. We then calculated the average of the SD in all VOIs for each muscle. We hypothesized that T 2 w standard deviation would be higher in GRMD versus normal dogs.
where I (x) is the intensity of voxel x,Ī is the mean intensity of a muscle in a VOI, and n is the number of voxels of a muscle in a VOI.
Three-dimensional run-length matrix features Compared to the histogram texture features, the run-length matrix features take into account both the intensity information and spatial distribution of voxels and thus nicely complement the histogram texture features.
A gray-level 'run' is defined as a set of consecutive voxels of similar intensity level in a given direction within a predefined similarity range, commonly chosen at 1.5 % of the full intensity range (as determined by 64 run-length matrix bins). An element of a standard run-length matrix measures the number of occurrences of a run with a specific length and specific intensity level in a given direction. However, such direction-specific run-lengths lack the power to characterize the 3D extension of the texture features in 3D MRI scans, because they only assess the intensity distribution in a single direction. In this study, we developed an extended method to directly measure 3D run-length matrix-based texture features.
First, to reduce the influence of voxels with very bright intensities caused by image noise, the top 5 % of the intensities were set to the value of the 95th percentile.
We then employed a grayscale 3D connected-component labeling technique to identify 3D run-length components with similar intensity for each muscle in each VOI. We chose a similarity range of 1.5 percent of the cropped intensity range. This allowed us to establish 3D run-length matrices for each VOI in each muscle, which assess run-lengths via 3D volumetric runs rather than the conventional, single-direction length measurements.
Finally, we calculated five commonly used run-length matrix features, including short run emphasis (SRE), long run emphasis (LRE), gray-level non-uniformity (GLN), runlength non-uniformity (RLN), and run percentage (RP) [35] , for each muscle in each VOI. We then calculated the average of each feature in all VOIs for each muscle.
Biomarker analysis
Our quantification tool was designed to measure a set of MR parameters and their changes across time. Because muscle atrophy/hypertrophy, inflammation, and fat infiltration are characteristic histopathological features of DMD/GRMD, MRI-derived biomarkers of interest within muscle regions included three categories of biomarkers: (i) muscle volume, (ii) mean intensities in FMs, WMs, and T2 maps, and (iii) statistical texture features. These biomarkers were used to longitudinally and cross-sectionally assess and compare the structural tissue changes of GRMD dogs and normal littermates. We performed the two-tailed t test assuming unequal variances to evaluate the group significant differences (p value < 0.05 was considered statistically significant) between normal and GRMD dogs. To examine the differences of the biomarkers between normal and GRMD groups along time, we conducted a mixed models statistical test [36] with an interaction term of time and group to test the longitudinally (at 3 month, 6 month, and 9 month) statistical differences (p value < 0.05 was considered statistically significant) between the two groups. In other words, we employed the mixed models to test the statistical difference of regression slopes of the proposed biomarkers in normal and GRMD groups.
Muscle volume Muscle volume was calculated straightforwardly from the muscle segmentation via voxel counting. Based on our previous studies [6, 19] , we hypothesized that most of the muscles of GRMD dogs would have smaller volumes than those of normal littermates; a notable exception is the CS, which is spared and may even undergo hypertrophy [19] followed by atrophy, with increased endomysial space due to fat and connective tissue.
Intensity map-based biomarkers For the biomarkers derived from FM, WM, and T2 value map, we computed the arithmetic mean after the application of an erosion operation with a circular kernel (radius = 3 voxels) on the muscle segmentation to reduce the influence of partial-volume voxels. We hypothesized that muscles of GRMD dogs would contain more fat and inflammation than normal dogs and thus have higher mean intensities in FM, WM, and T2 value map than normal dogs.
Statistics of texture analysis-based biomarkers
For the statistical texture-based biomarkers, we also computed the arithmetic mean on the eroded muscle segmentations. For these biomarkers, we hypothesized that muscles of GRMD dogs would contain more fat and inflammation than normal dogs, and thus, (i) GRMD dogs would have higher SD of histogram than normal dogs; (ii) GRMD dogs would have higher SRE, GLN, RLN, and RP of run-length matrix than normal dogs; and (iii) GRMD dogs would have lower LRE of run-length matrix than normal dogs. Figure 3 shows the mean value with standard error of the biomarkers of each muscle in normal and GRMD dogs at 3, 6, and 9 months of age, respectively. Normal muscles had consistently larger volumes (two tailed t test assuming unequal variance for all the data of normal and GRMD dogs, p = 0.002) and had lower T2 value map ( p < 0.001), FM ( p = 0.002), and WM ( p < 0.001) values when compared to GRMD dogs at most of the age points, except for FM at 3 months of age. With respect to longitudinal changes of these markers across time, the normal and GRMD dogs show no significant differences in FM (mixed models, p = 0.200), WM ( p = 0.507), and T2 value map ( p = 0.908), whereas significant longitudinal group differences were identified for muscle volumes ( p < 0.001). Figure 4a shows the average value of SD of histogram with standard error of muscles in T 2 w of normal and GRMD dogs at 3, 6, and 9 months of age. Overall, the SD differed significantly between normal and GRMD ( p < 0.001), whereas the SD did not show significant difference between normal and GRMD dogs (p = 0.327) over age. Figure 4b -f show the run-length matrix texture features with standard error for each muscle in normal and GRMD dogs at 3, 6, and 9 months of age, respectively. Overall, the SRE ( p < 0.001), GLN ( p < 0.001), RLN ( p < 0.001), and RP ( p < 0.001) of GRMD muscles were higher, while the LRE ( p < 0.001) was lower, when compared to normal muscles at each age. With respect to longitudinal changes across time, the change trend for SRE ( p = 0.587), LRE ( p = 0.153), GLN ( p = 0.059), RLN ( p = 0.054), and RP ( p = 0.519) did not show significant longitudinal differences between normal and GRMD dogs in the small sample size study presented in this paper. Therefore, although the statistical texture biomarkers proposed in this study showed their abilities to identify the group differences between normal and GRMD dogs, the study was underpowered to show significant longitudinal differences between normal and GRMD dogs.
Results
Muscle segmentation is an essential step for the quantification tool. Table 2 shows the imaging-map-based biomarkers calculated from the interpolation-based muscle segmentation and reference muscle volume of two normal dogs and two GRMD dogs in CS, RF, and ST. The average percent error ratios Eq. (1) over the mean intensities of FM, WM, and T2 value map were quite low at 1.28, 0.73, and 0.40 %, respectively. We also calculated the biomarker performance from the limited-range muscle segmentation (only five consecutive mid-femur slices). The average error ratios over the mean intensities of FM, WM, and T2 value map were considerably higher at 28.12, 2.70, and 2.95 %, respectively. Overall, the errors were an order of magnitude larger in the limited-range muscle segmentations than in the interpolated full muscle segmentations. By use of the paired two-tailed t test, we found that the errors were significantly higher in the limited-range muscle segmentation than in the interpolated full muscle segmentation (p = 0.001, p = 0.04, p = 0.04 for FM, WM, and T2 value map, respectively). In order to test whether the above results may be true in GRMD only, we investigated the Table 2 The average difference of the biomarkers calculated from the interpolation-based muscle segmentation and the reference manual full muscle segmentation and the average difference of the biomarekers from the manual muscle segmentation in a limited range (five slices) and reference muscle segmentation of two normal dogs and two GRMD dogs in cranial sartorius (CS), rectus femoris (RF), and semitendinosus (ST) average error ratios Eq. (1) over the mean intensities of FM, WM, and T2 value map derived from limited-range muscle segmentation for the two GRMD and normal dogs separately. The average error ratios for FM, WM, and T2 value of the GRMD dogs were 32.33, 4.19, and 2.75 %, respectively. The average error ratios for FM, WM, and T2 value of the normal dogs were 23.91, 1.21, and 3.14 %, respectively. This result showed that overall the GRMD dogs contributed more to the elevated errors for the biomarker derived from the limitedrange muscle segmentation in this small data set. The main reason for this result is that the muscles of normal dogs may contain less intensity heterogeneity in MRI. We also investigated the segmentation inter-rater variability between ZF and JW on the semiautomated segmentation scheme ( Table 3 ). The comparison results showed that the average performance across raters over mean intensities in FM, WM, and T2 value map were appropriately low at 6.36, 5.28, and 1.21 %, respectively. The inter-rater variability for normal and GRMD dogs showed similar performance ( p > 0.99). This relatively small inter-rater difference indicates that our biomarker quantification tool is reliable and stable.
The T2 value maps covered the mid-femur section of the proximal pelvic limbs (section "Study subjects"). As described above, MRI biomarkers calculated from full muscle segmentation showed considerably less error than from limited-range muscle segmentations. Thus, a T2 value map should ideally cover the entire length of a muscle or at least a large segment of the muscle to maximize the number of pixels included in the calculation. As a result of experiments presented here, we modified our imaging protocol in ongoing Table 4 for T2 value-based biomarker results). The average biomarker difference between limited and full muscle segmentations for T2 value map was 15.14 % ( p < 0.0001). This suggests that the T2 value-based biomarker should also be assessed within the full muscle or to include enough pixels within a given muscle to minimize the effects of sampling error.
Discussion
Muscle segmentation plays an important role in DMD MRI biomarker quantification. The results from our study demonstrated that MRI biomarkers computed from the muscle regions determined by semiautomated full muscle segmentation have lower error ratios than biomarkers from regions determined by the standard limited-range manual muscle segmentations (5 mid-femur slices). For the muscle volume, one could expect that full muscle segmentation would provide more accurate measurement results than in limitedrange segmentation. The magnitude of the error observed in the other biomarkers was more surprising. This result is likely due to the inhomogeneous nature of muscle lesions in DMD/GRMD subjects. Furthermore, it strongly highlights that the whole or at least a large segment of the muscle should ideally be segmented to minimize sampling error while excluding irrelevant surrounding tissues. Our experimental results showed that a straightforward interpolation scheme allowed computation of a fairly stable and accurate set of MRI biomarkers. In this study, the proposed biomarkers were reported without normalization by body weight of the dog. Body weight or body size normalization is commonly used to reduce the inter-subject variation in the biomarker measurement. Because of the loss of muscle mass, the affected GRMD dogs generally have lower body weight and smaller muscle volume compared to control dogs. If the muscle volume was normalized by the body weight, the effect of this marker on discriminating GRMD and normal dogs would be diminished, which is why for GRMD/DMD studies body weight normalization is often not performed. For clinical studies, we suggest that the imaging biomarkers of GRMD muscles should be analyzed both with and without normalization by dog size (body weight).
Although the muscles of normal dogs may contain less heterogeneity, the quantification at mid-femur still may not be optimal in normal dogs, because not all the muscles are located equally central to the mid-femur. For instance, the mid-femoral point generally only captures the far distal part of the gracilis. Because the sectional area of the distal is small, the quantification would be highly affected by the human errors (muscle segmentation) and image noises. We have calculated the difference of biomarkers derived from interpolation-based full muscle segmentation and the limited-range muscle segmentation over all normal dog scans (20 scans) in our study for CS, RF, and ST. The result shows comparable error levels (21.27, 4.80, and 2.94 % for FM, WM, and T2 value, respectively) to the ones shown in Table 2 (28.12, 2.70, and 2.95 % for FM, WM, and T2 value, respectively). While there is no ground truth of full muscle segmentation available for all these scans, it can safely be said that the interpolation-based full muscle and mid-femur limited muscle biomarkers show large differences. Given that the interpolation-based full muscle segmentation showed clearly better performance when compared to cases with ground truth (Table 2) , this indicates that limiting the segmentation to a small range introduces significant variation/errors in MR biomarker measurements. Thus, the interpolation-based whole muscle segmentation scheme allowed us to compute fairly stable and accurate values for the biomarkers, whereas the limited-range segmentation-based measures show higher variance and errors. The main reason for this effect is the inhomogeneous appearance of GRMD muscle lesions such that highly lesioned areas in one GRMD subject could be sampled and relatively low lesioned areas would be sampled in another one.
The overall computational scheme of this tool is composed of "automatic" and "interactive" processing steps. The automatic processing part consists of the preprocessing and biomarker calculation. The average automatic processing time is about 15 min/scan (CentOS 5.6 Linux, Intel 64 bit 1.66 GHz quad-core, 128GB RAM). The interactive processing part consists of the muscle segmentation and identification of subcutaneous fat regions, in which muscle segmentation is the most labor-intensive task. Manual full muscle segmentation for each muscle would require an average of 60 min, whereas the semiautomated muscle segmentation for each muscle, including the manual delineation of muscle regions in every 5th slice and the automated segmentation interpolation, averaged less than 15 min. Our experimental results indicate that the target segmentation accuracy requirements of the automatic muscle segmentation are relatively relaxed, as the GRMD biomarkers could be estimated fairly stably in the presence of smaller segmentation errors (as were likely present in these semiautomated segmentations). In our ongoing research, we are investigating the use of fully automated multi-atlas-based muscle segmentation schemes.
While fat ultimately increases histologically in both DMD and GRMD, the relatively young age of these dogs and short 6-9 months time course of the study may not have been sufficient to capture more chronic fatty infiltration. Another potential reason is the inherently large variability of the fat measures in images acquired with the selected fat suppression-based MR protocols. Ultimately spectroscopic methods such as proton MR spectroscopy may be more sensitive to these early, small changes in lipid levels at low fat fractions.
We observed that T 2 w and T 2 fs images generally contain higher intensity inhomogeneities than the T2 value maps. Although we applied the N4 algorithm to correct intensities, the strong intensity inhomogeneity in T 2 w and T 2 fs could not be completely eliminated. Furthermore, the T 2 w and T 2 fs images were calibrated using manually identified subcutaneous fat. Because the manual identification of subcutaneous fat is subject to human rater error, the intensity calibration may not be fully accurate. It was, therefore, not surprising to find that the inherently intensity calibrated T2 value map-based biomarkers were more reliable than those of our fat and water map-based biomarkers.
Although the statistical texture analysis technique has been used in many imaging applications of muscle diseases, to our knowledge, it has not been widely used for studies of muscular dystrophy. One characteristic histopathologic feature of DMD and GRMD is the patchy, inhomogeneous and differential involvement of lesions within even the same muscle. The commonly used mean intensity marker will not be sufficiently sensitive to capture this characteristic inhomogeneity. In this study, we employed histogram features and adapted 3D run-length matrix features to investigate the difference in MR appearance of normal and GRMD muscles cross-sectionally and longitudinally across time. Because of fatty change, one would expect GRMD muscles to have coarser texture than normal muscles. Therefore, the affected muscles would have more short runs, less long runs, and a higher total number of runs than normal muscles. Furthermore, because muscle lesions are irregular, the uniformity in the distribution of runs over gray levels and over the lengths of runs would generally be higher in affected versus normal muscles. For these reasons, the run-length matrix features distinguished GRMD from normal muscles. Overall, the statistical texture biomarkers had advantages in quantifying group differences for the GRMD and normal dogs and longitudinal disease progression in GRMD dogs, suggesting that these biomarkers will be useful in DMD clinical trials.
A limitation of this study is the lack of validation of the proposed methods using histopathologic and functional measurements. In fact, the histopathologic/functional correlation study for validating the proposed markers is ongoing, using functional indices of isometric distal limb force [37] and repeated eccentric contractions; muscle weight; and histopathological measures of myofiber and endomysial space (non-contractile tissue) per unit area [38, 39] . We will report this histopathologic/functional finding-based validation study in our future publications.
As a final note, we plan to disseminate this biomarker quantification tool publicly as open source on NIH's NeuroImaging Toolkit and Resource Clearinghouse (NITRC, http://www.nitrc.org/). We hope this quantification tool will constitute a valuable resource for the DMD research community.
Conclusions
In this study, we developed a semiautomated MRI biomarker quantification tool incorporating enhanced histogram-based statistical texture features and novel 3D run-length matrixbased statistical texture biomarkers in the GRMD model of DMD. Our quantification tool showed clear group differences for the affected and normal dogs, albeit with operator input for the segmentation of muscles and subcutaneous fat regions. Our quantification tool provided useful MRI biomarkers for GRMD. However, it also had some limitations: (i) The muscle segmentation method was not fully automated and required human rater input; (ii) the subcutaneous fat regions were identified manually for the intensity calibration; and (iii) the intensity inhomogeneous correction was imperfect. In our ongoing research, we are focusing on development of fully automated muscle segmentation techniques to promote efficiency and reliability of our scheme.
